L Scappaticcio, P Caruso, N Di Martino, P Ferrazzano, A Clemente, M I Maiorino, A Regginelli, G Docimo, P F Rambaldi, G Bellastella, P Trimboli, S Cappabianca, K Esposito
PURPOSE: Abnormal liver blood tests (ALBTs), neutropenia (NEU) and thymic hyperplasia (TH) are new features of Graves' disease (GD). Our objectives were: (a) to calculate the accuracy of TH in discriminating between Graves' and non-Graves' thyrotoxicosis, compared to ALBTs, NEU and Graves' orbitopathy (GO); (b) to explore the outcome of GD-associated TH and non-GD-associated TH. METHODS: We prospectively analyzed consecutive adult patients with newly diagnosed thyrotoxicosis from January 2018 to June 2023...
March 30, 2024: Journal of Endocrinological Investigation